2005
Brown LB, Stern RA, Cahn-Weiner DA, Rogers B, Davis MA, Lannon MC, Maxwell C, Souza T, White T, Ott BR. Driving Scenes test of the Neuropsychological Assessment Battery (NAB) and on-road driving performance in aging and very mild dementia. Archives of Clinical Neuropsychology 2005; 20: 209-215. [PDF]
Budson AE, Dodson CS, Vatner JM, Daffner KR, Black PM, Schacter DL. Metacognition and false recognition in patients with frontal lobe lesions: The distinctiveness heuristic. Neuropsychology 2005; 43: 860-871. [PDF]
Budson AE, Price BH. Memory dysfunction. The New England Journal of Medicine, 2005; 352 692-9. [PubMed]
Christensen DD, Green RC: Disease modifying therapies for Alzheimer’s disease: Update on emerging treatments. CNS News, November, 2005, pp 21-26.
Green RC: Diagnosis and Management of Alzheimer’s Disease and Other Dementias, Professional Communications, Inc., New York, First Edition, 2001; Second Edition, 2005.
Henderson VW, Benke KS, Green RC, Cupples LA, Farrer LA. Postmenopausal hormone therapy and Alzheimer's disease risk: Interaction with age. Journal of Neurology, Neurosurgery and Psychiatry 2005; 76:103-105. [PDF]
Hurley AC, Harvey R, Roberts JS, Wilson-Chase C, Lloyd S, Prest J, Lock M, Horvath KJ, Green RC. Genetic susceptibility for Alzheimer's disease: Why did adult offspring seek testing? American Journal of Alzheimer's Disease and other Dementias 2005; 20: 374-381. [PubMed]
LaRusse S, Roberts JS, Marteau TM, Katzen H, Linnenbringer EL, Barber M, Whitehouse P, Quaid K, Brown T, Green RC, Relkin NR. Genetic susceptibility testing versus family history-based risk assessment: Impact on perceived risk of Alzheimer disease. Genet Med 2005; 7:48-53. [PubMed]
Lyketsos CG, Toone L, Tschanz J, Rabins PV, Steinburg M, Onyike CU, Corcoran C, Norton M, Zandi P, Breitner JC, Welsh-Bohmer K, Anthony J, Ostbye T, Bigler E, Pieper C, Burke J, Plassman B, Green RC, Steffens DC, Klein L, Leslie C, Townsend JJ, Wyse BW, Munger R, Williams M. Population-based study of medical comorbidity in early dementia and "cognitive impairment, no dementia (CIND)": association with functional and cognitive impairment : The Cache County Study. American Journal of Geriatric Psychiatry 2005; 13: 656-664. [PubMed]
Marteau T, Roberts JS, LaRusse SA, Green RC. Genetic susceptibility testing versus family history-based risk assessment. Impact upon perceived risk of Alzheimer's disease. Risk Analysis 2005; 25: 397-404.
Roberts JS, Cupples LA, Relkin NR, Whitehouse PJ, Green RC. Genetic risk assessment for older adult children of people with Alzheimer's disease. Journal of Geriatric Psychiatric Neurology 2005; 18: 250-255. [PubMed]
Tan ZS, Seshadri S, Beiser A, Zhang Y, Felson D, Hannan MT, Au R, Wolf PA, Kiel DP. Bone Mineral Density and the Risk of Alzheimer's Disease. Archives of Neurology 2005; 62:107-111. [PDF]
Yip AG, Green RC, Huyck M, Cupples LA, Farrer LA. Nonsteroidal anti-inflammatory drug use and Alzheimer disease risk: The MIRAGE Study. Biomed Central Geriatrics 2005; 5:2.
Yip G, McKee A, Green RC, Wells J, Young H, Cupples LA, Farrer LA. APOE, vascular pathology, and the AD brain. Neurology 2005; 65: 259-265. [PDF]
Zick C, Mathews C, Roberts JS, Cook-Deegan R, Pokorski R, Green RC. Genetic susceptibility testing for Alzheimer’s disease and its impact on insurance behavior. Health Affairs 2005; 24(2):483-490.[PDF]
|
|
